In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Bespak makes appointment:

This article was originally published in Clinica

Executive Summary

Bespak (Milton Keynes, UK), specialist in drug delivery devices, has appointed Scott Kellogg as its new commercial manager, in a bid to enhance their US commercial team. Mr Kellogg will be based in Palm Harbour, Florida, where he will provide a link with Nektar Therapeutics, designers of the PDS device used to deliver the inhaled insulin therapy, Exubera. He will also be in charge of generating new business opportunities for the manufacturing services division. Mr Kellogg was previously the quality manager and lead program Manager for injection moulding and contract-manufacturing firm FCM.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts